Frankfurt - Delayed Quote EUR
Enlivex Therapeutics Ltd. (1BT.F)
0.7950
+0.0150
+(1.92%)
As of 8:02:51 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-14,201
-23,523
-23,953
-17,542
-11,007
Investing Cash Flow
9,836
-25,968
62,524
-38,408
-20,977
Financing Cash Flow
5,193
360
150
60,982
33,082
End Cash Position
3,196
1,226
50,357
11,636
7,012
Capital Expenditure
-75
-236
-8,122
-1,625
-1,019
Issuance of Capital Stock
5,193
360
--
53,174
24,467
Free Cash Flow
-14,276
-23,759
-32,075
-19,167
-12,026
12/31/2020 - 7/23/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PYPD PolyPid Ltd.
2.7100
-1.45%
BCDA BioCardia, Inc.
1.9150
+2.96%
CELU Celularity Inc.
1.6700
+3.73%
ALZN Alzamend Neuro, Inc.
0.6793
-0.85%
CVKD Cadrenal Therapeutics, Inc.
16.89
+0.06%
BCLI Brainstorm Cell Therapeutics Inc.
0.8607
-0.97%
LGVN Longeveron Inc.
1.6100
0.00%
BSEM BioStem Technologies, Inc.
12.43
+6.24%
LXEO Lexeo Therapeutics, Inc.
3.4400
+2.08%
VIR Vir Biotechnology, Inc.
6.10
+2.18%